FindTrial
Sign In

Botulinum toxin injection for complex regional pain syndrome

Relationship between dose and analgesic effect of botulinum toxin injection to lumbar sympathetic ganglion for the patients of complex regional pain syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005875
Enrollment
30
Registered
2021-02-08
Start date
2021-01-27
Completion date
Unknown
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 19 years old or older Patients who saw complex pain syndrome as a diagnosis at our pain center For patients who underwent lumbar sympathetic nerve block using Botox

Exclusion criteria

Exclusion criteria: Infection malignancy Bleeding tendency Pregnant, lactating Patients with spinal cord stimulator or drug injection pump inserted

Design outcomes

Primary

MeasureTime frame
Numeric rating scale;Oswestry disability index;Leeds Assessment of Neuropathic Symptoms and Signs;EuroQol five-dimension scale—

Secondary

MeasureTime frame
Safety assessment—

Countries

Korea, Republic of

Contacts

Public ContactJi Yeong Kim

The Catholic University of Korea, Seoul St. Mary's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026